Hims & Hers was rated Hold amid margin pressure, Amazon-driven competition, & uncertain catalysts. Learn more about HIMS ...
The Goldman Sachs Group (NYSE:GS) reported what CEO David Solomon called “strong performance” in the fourth quarter of 2025, highlighting improved returns, continued momentum in its Global Banking & ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback